NPCUF   $0.03  14900.00% Market Closed

Allon Therapeutics Inc
Total Cash 589.48K
totalCashPerShare 0.004
EBITDA -8.73M
Total Debt 184.51K
quickRatio 0.254
currentRatio 0.312
Total Revenue
debtToEquity
Revenue/Share
ROA -1.54843
ROE
grossProfits
freeCashflow -4.52M
operatingCashflow -7.65M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -390.86K
forwardPE
floatShares
sharesOutstanding
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.0
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.013
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -13.21M
trailingEps
forwardEps
enterpriseToEbitda 0.04
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Nov. 7, 2024, 12:43 a.m.